United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine solution, usp is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post-traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine solution, usp administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate trea

Ireland - English - HPRA (Health Products Regulatory Authority)

stirling anglian pharmaceuticals ltd - acetylcysteine - effervescent tablet - 600 milligram(s) - mucolytics; acetylcysteine

Ireland - English - HPRA (Health Products Regulatory Authority)

stirling anglian pharmaceuticals ireland limited - acetylcysteine - effervescent tablet - 600 milligram(s) - mucolytics; acetylcysteine

Canada - English - Health Canada

sandoz canada incorporated - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

Canada - English - Health Canada

hikma canada limited - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes

United States - English - NLM (National Library of Medicine)

apotheca company - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine chloride 30 [hp_c] in 1 ml - indications:   for temporary relief of dizziness, chest congestion with mild constriction, fatigue, cough, headaches, forgetfulness and drowsiness. indications:   for temporary relief of dizziness, chest congestion with mild constriction, fatigue, cough, headaches, forgetfulness and drowsiness.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine 6 [hp_x] in 1 ml - for temporary relief of chest congestion with mild constriction, indigestion, drowsiness, headache, forgetfulness, and general fatigue. for temporary relief of chest congestion with mild constriction, indigestion, drowsiness, headache, forgetfulness, and general fatigue.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine 6 [hp_x] in 1 ml - for temporary relief of symptoms including dizziness, chest congestion, cough, fatigue, rash, itching, headache and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms including dizziness, chest congestion, cough, fatigue, rash, itching, headache and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine injection is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions ( 5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and